SEC 13F Intelligence

Managers / Q3 2020 · view latest →

Corriente Advisors, LLC

CIK 0001406718 · 1401 FOCH ST, SUITE 100, FORT WORTH, TX, 76107 · 8178700400

Reported Value
$197M
Q3 2020
Positions
16
Filings on Record
17
2020–present window
Filed
Nov 3, 2020
original filing

Summary

Corriente Advisors, LLC reported $197M in U.S.-listed holdings across 16 positions for Q3 2020.

The portfolio is heavily concentrated: Maxar Technologies alone accounts for 24.9% of reported value.

Compared with Q2 2020, the fund opened 9 new positions and exited 9.

Portfolio Metrics

Turnover
+28.1%
vs prior filed quarter
Top-10 Concentration
+91.2%
share of reported value
Largest Position
+24.9%
Maxar Technologies
New / Exited
9 / 9
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’19: $186MQ4 ’19Q1 ’20: $93MQ2 ’20: $154MQ2 ’20Q3 ’20: $197MQ4 ’20: $420MQ4 ’20Q1 ’21: $272MQ2 ’21: $185MQ2 ’21Q3 ’21: $52MQ4 ’21: $12MQ4 ’21Q1 ’22: $268MQ2 ’22: $237MQ2 ’22Q3 ’22: $90MQ4 ’22: $0Q4 ’22Q1 ’23: $976,400Q2 ’23: $10,872Q2 ’23Q4 ’23: $10Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 86.4%Other: 13.6%
  • Common Stock · 86.4% · $170M
  • Other · 13.6% · $27M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2020 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
TFF PHARMACEUTICALS INCNEW+1.06M1.06M+$20M$20M
BYNDBEYOND MEAT INCNEW+35.0K35.0K+$6M$6M
VIRGIN GALACTIC HOLDINGS INCNEW+250.0K250.0K+$5M$5M
VFFVILLAGE FARMS INTL INCNEW+943.4K943.4K+$4M$4M
DDOGDATADOG INCNEW+40.0K40.0K+$4M$4M
AXOVANT SCIENCES LTDNEW+875.0K875.0K+$4M$4M
ROKUROKU INCNEW+20.0K20.0K+$4M$4M
AURYN RESOURCES RESTRICTEDNEW+1.50M1.50M+$2M$2M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2020

16 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1MAXAR TECHNOLOGIES INCCOM24.94%$49M1.97M
2REATA PHARMACEUTICALS INCCL A14.82%$29M300.0K
3CUE BIOPHARMA INCCOM10.97%$22M1.44M
4APTOSE BIOSCIENCES INCCOM NEW10.44%$21M3.43M
5TFF PHARMACEUTICALS INCCOM9.92%$20M1.06M
6CRDFCARDIFF ONCOLOGY INChistory →COM6.55%$13M910.0K
7REPLREPLIMUNE GROUP INChistory →COM5.98%$12M512.5K
8BYNDBEYOND MEAT INChistory →COM2.95%$6M35.0K
9VIRGIN GALACTIC HOLDINGS INCCOM2.44%$5M250.0K
10VFFVILLAGE FARMS INTL INChistory →COM2.19%$4M943.4K
11DDOGDATADOG INChistory →CL A COM2.07%$4M40.0K
12AXOVANT SCIENCES LTDCOM2.05%$4M875.0K
13ROKUROKU INChistory →COM CL A1.91%$4M20.0K
14DMACDIAMEDICA THERAPEUTICS INChistory →COM NEW1.57%$3M730.0K
15AURYN RESOURCES RESTRICTEDSTOCK1.14%$2M1.50M
16CHIMERIX INCCOM0.06%$122,00049.1K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q4 2023$10M3Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023Under review7Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$10,8722Aug 9, 202313F-HRchanges · EDGAR ↗
Q1 2023$976,4002May 10, 202313F-HRchanges · EDGAR ↗
Q4 2022$01Feb 15, 202313F-HRchanges · EDGAR ↗
Q3 2022$90M5Nov 15, 202213F-HRchanges · EDGAR ↗
Q2 2022$237M5Aug 16, 202213F-HRchanges · EDGAR ↗
Q1 2022$268M5May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$12M3Feb 15, 202213F-HRchanges · EDGAR ↗
Q3 2021$52M8Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$185M15Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$272M10May 18, 202113F-HRchanges · EDGAR ↗
Q4 2020$420M19Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$197M16Nov 3, 202013F-HRchanges · EDGAR ↗
Q2 2020$154M16Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$93M11May 18, 202013F-HRchanges · EDGAR ↗
Q4 2019$186M17Feb 14, 202013F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.